Company Filing History:
2 out of 4,455 
2 out of 15,475 
Years Active: 2022-2025
Title: Matthew Ross Drever: Innovator in Cancer Treatment
Introduction
Matthew Ross Drever is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies. With a total of 2 patents, Drever's work focuses on the application of anti-AV8 antibodies in medical treatments.
Latest Patents
Drever's latest patents include a method of treating cancer using anti-AV8 antibodies. This invention provides antibodies and antigen-binding fragments that specifically bind to αvβ8 integrin. The invention encompasses various uses and associated methods of utilizing these antibodies. Another significant patent is for anti-AVB8 antibodies and compositions, which also specifically bind to αvβ8 integrin, including their uses and methods of application.
Career Highlights
Throughout his career, Drever has worked with prominent organizations such as Pfizer Corporation and the University of California. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Drever has collaborated with notable colleagues, including Kyle Steven Niessen and Dharmaraj Samuel, enhancing the impact of his work through teamwork and shared expertise.
Conclusion
Matthew Ross Drever's innovative contributions to cancer treatment through his patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire future research in the field.